Calls
1
u/Correct_Proposal_409
Reddit r/pennystocks
Win Rate
0.0%
return
-46.8%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 02
$3.33
-46.8%
The author claims GT-02287's 75–95% reduction in CSF GluSph shows lysosomal function is restored and could make it the first disease-modifying Parkinson's therapy. Because the Parkinson's market could reach $100–200B/year and the drug is de-risked by biomarker data, a large pharma could acquire it for $1–10B, implying a 6–60x return from current market cap. The investment mechanism is a buyout premium or re-rating as more clinical data confirm preclinical findings.
Other
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/Correct_Proposal_409 has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: GANX.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
